Download: Exploring the global Pharma M&A market

Andrew Badrot, Founder of CMS Pharma kindly shared his thoughts on the Pharma M&A market, the challenges being faced and what companies can do to overcome the hurdles. Download a copy here The Pharma Mergers and Acquisitions market has recently seen a lot of traffic, with deals between GlaxoSmithKline and Novartis, whilst Pfizer has made overtures to AstraZeneca. With activity …

big pharma firepower in global pharma m&a

Big pharma’s position in global pharma M&A – exploring EY’s ‘Firepower’ report

Last year saw pharmaceutical mergers and acquisitions increase by $45 billion (click here to read a recent Total Biopharma post about it). However, the activities of big pharma in these M&As were somewhat marginalised, with the majority of acquisitions completed by speciality pharma and big biotech. As reported in Financier.com, Ernst & Young’s report, ‘Firepower and Growth Gap’, states that …